Status:

COMPLETED

Estimate of the Activity and the Forecast of the Lupus Disease of the Adult by a Transcriptomic Score (STUDY LU-PUCE)

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Lupus Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Lupus erythematosus systemic is an auto-immune disease the evaluation of the activity of which remains very difficult because of an heterogeneousness of the clinical and biological symptoms. The aim o...

Eligibility Criteria

Inclusion

  • Lupus disease diagnosed for lupus disease arm
  • Signed assent

Exclusion

  • non-compliance
  • pregnancy
  • persons without social coverage

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2012

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00920114

Start Date

May 1 2009

End Date

March 1 2012

Last Update

September 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique-Hopitaux de Marseille

Marseille, France

Estimate of the Activity and the Forecast of the Lupus Disease of the Adult by a Transcriptomic Score (STUDY LU-PUCE) | DecenTrialz